文献速递呼吸道感染呼吸危重症与机械通气

嗜肺军团菌所致重症社区获得性肺炎合并急性呼吸衰竭34例临床特征与预后

[Severe community-acquired pneumonia caused by Legionella pneumophila with acute respiratory failure: clinical characteristics and prognosis of 34 cases].
PubMed 文献 · Zhonghua Jie He He Hu Xi Za Zhi · 2020-01-01

回顾性分析2011年10月至2019年10月北京朝阳医院RICU收治的34例嗜肺军团菌所致重症社区获得性肺炎合并急性呼吸衰竭患者,男性25例、女性9例,中位年龄61(48,69)岁。RICU病死率29%,SOFA评分升高与启动针对性治疗延迟是RICU病死率升高的独立危险因素。

要点

  • 重症军团菌肺炎合并急性呼吸衰竭患者RICU病死率29%。
  • SOFA评分升高是RICU病死率升高的独立危险因素。
  • 肺炎症状至启动针对性治疗时间延长与病死率升高相关。

核心结论

  • RICU中重症军团菌肺炎合并急性呼吸衰竭患者病死率较高。
  • 严重脏器功能不全与启动针对性治疗延迟与RICU病死率升高有关。

研究设计与样本

  • 回顾性收集2011年10月至2019年10月入住北京朝阳医院RICU的34例重症军团菌肺炎合并急性呼吸衰竭病例。
  • 按RICU住院期间是否死亡分为存活组24例与死亡组10例进行对比分析。
  • 采用多因素logistic回归分析住院病死率危险因素。

主要发现

  • 34例中男25例、女9例,年龄17~82岁,中位年龄61(48,69)岁。
  • 死亡组SOFA评分9(7,12)分,显著高于存活组4(3,8)分,P=0.018。
  • 死亡组肺炎症状至启动针对性治疗时间10(7,14)d,显著长于存活组4(3,7)d,P=0.019。
  • RICU住院期间死亡10例,病死率29%。
  • 氧合指数134(91,216)mmHg,住RICU中位时间12(7,22)d。

关键数值与推荐

  • SOFA评分升高为RICU病死率升高的独立危险因素(OR=1.461,95%CI 1.041~2.051,P=0.028)。
  • 肺炎症状至启动针对性治疗时间延长为RICU病死率升高的独立危险因素(OR=1.293,95%CI 1.029~1.625,P=0.027)。

临床怎么用

  • 对重症军团菌肺炎合并急性呼吸衰竭患者应尽早启动针对性治疗。
  • 应动态评估SOFA评分以识别高死亡风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To describe the clinical characteristics and treatment of severe community-acquired pneumonia(SCAP) caused by Legionella pneumophila with acute respiratory failure and to analyze the risk factors for mortality. Methods: From October 2011 to October 2019, 34 patients were diagnosed with SCAP caused by Legionella pneumophila with acute respiratory failure.There were 25 males and 9 females, aged from 17 to 82 years, with a median age of 61 (48, 69) years. According to the prognosis, the patients were divided into a survival group and a death group for comparative analysis.The survival group included 24 patients, 17 males and 7 females, with a median age of 65 (55, 70) years. There were 10 cases in the death group, 8 males and 2 females, with a median age of 53 (50, 58) years. Multivariable logistic regression analysis was used for risk factors of ICU mortality. Results: The median time of admission to ICU was 7 (5, 11) days, the median time of stay in RICU was 12 (7, 22) days, and the PaO(2)/FiO(2) was 134 (91, 216) mmHg(1 mmHg=0.133 kPa). Ten patients died during ICU hospitalization, with a mortality of 29%. Sequential organ failure assessment (SOFA) of death group was 9 (7, 12), which was significantly higher than that of the survival group [4 (3, 8)], P=0.018. The time from onset of pneumonia symptoms to initiation of targeted treatment of the death group was 10 (7, 14) d, which was significantly longer than that of the survival group of [4 (3, 7) d], P=0.019. Multivariable logistic regression analysis showed that SOFA score (OR=1.461, 95%CI 1.041-2.051, P=0.028) and the time from onset of pneumonia symptoms to initiation of targeted treatment (OR=1.293, 95%CI 1.029-1.625, P=0.027) were independent risk factors for hospital mortality. Conclusions: The ICU mortality of severe legionella pneumonia was high. Critical organ dysfunctions and delayed initial targeted treatment were related with the increase of ICU mortality. 目的: 探讨重症军团菌肺炎合并急性呼吸衰竭患者的临床特点及影响预后的因素。 方法: 收集2011年10月至2019年10月入住首都医科大学附属北京朝阳医院呼吸重症监护病房(RICU)的34例重症军团菌肺炎合并急性呼吸衰竭病例,并应用多因素logistic回归分析法分析住院患者的病死率及其危险因素。 结果: 34例患者中男25例,女9例,年龄17~82岁,中位年龄为61(48,69)岁。34例患者按是否在RICU住院期间死亡分为死亡组和存活组。存活组24例,男17例,女7例,中位年龄为65(55,70)岁;死亡组10例,男8例,女2例,中位年龄为53(50,58)岁。出现肺炎相关症状至入住RICU的中位时间为7(5,11)d,氧合指数为134(91,216)mmHg(1 mmHg=0.133 kPa),住RICU的中位时间为12(7,22)d。死亡组患者序贯器官衰竭(SOFA)评分为9(7,12)分,显著高于存活组的4(3,8)分(P=0.018);死亡组出现肺炎症状至启动针对性治疗的时间为10(7,14)d,显著高于存活组的4(3,7)d(P=0.019)。多因素logistic回归分析结果显示,SOFA评分升高(OR=1.461,95%CI为1.041~2.051,P=0.028)和出现肺炎症状至启动针对性治疗的时间延长(OR=1.293,95% CI为1.029~1.625,P=0.027)是RICU内病死率升高的独立危险因素。 结论: RICU中重症军团菌肺炎合并急性呼吸衰竭患者的病死率较高,严重脏器功能不全、启动针对性治疗的时间延迟与RICU病死率升高有关。.

来源:Zhonghua Jie He He Hu Xi Za Zhi,查看原文。版权归原作者所有。

引用

  1. He CW, Tang X, Sun B, et al. [Severe community-acquired pneumonia caused by Legionella pneumophila with acute respiratory failure: clinical characteristics and prognosis of 34 cases]. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32629554. doi:10.3760/cma.j.cn112147-20200114-00023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。